Skip to content
value.today

Relypsa Inc

🇺🇸 Santa Clara, California, USABiotechnologyFounded 2007
Total raised
$135 M
2 rounds on record
Latest round
$65 M
Jul 2012
First round on record
Sep 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Relypsa Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2012$65 MNo. 2$50 to $250 million

Relypsa Inc: Raise no. 2, Jul 2012

Investors in this round

15 investors had bought by the notice of Dec 11, 2012: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Relypsa Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$65 M of $80 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Claire M. Lockey · Executive Officer
  • Gerrit Klaerner · Executive Officer, Director
  • Jerry M. Buysse · Executive Officer
  • Lance M. Berman · Executive Officer
  • Ronald Krasnow · Executive Officer
  • Wilhelm M. Stahl · Executive Officer
  • Jonathan M. Silverstein · Director
  • Klaus M. Veitinger · Director
  • Paul M. Hastings · Director
  • Ron M. Hunt · Director
  • Scott M. Rocklage · Director
  • Thomas M. Schuetz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald Krasnow, Secretary. Source: SEC Form D and 2 amendments, newest notice filed Dec 11, 2012. Read the notice at the SEC.

equity, optionsSEC
Sep 2010$70 MNo. 1$50 to $250 million

Relypsa Inc: Raise no. 1, Sep 2010

Investors in this round

12 investors had bought by the notice of Aug 8, 2011: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 11 investors are named for Relypsa Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$70 M of $70 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Series B-1 Preferred Stock, Series B-2 Preferred Stock and Series B Preferred Stock and Common Stock issuable upon conversion thereof.
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerrit Klaerner · Executive Officer, Director
  • Jerry M. Buysse · Executive Officer
  • Ronald Krasnow · Executive Officer
  • Deepa M. Pakianathan · Director
  • Jonathan M. Silverstein · Director
  • Klaus M. Veitinger · Director
  • Scott M. Rocklage · Director
  • Thomas M. Schuetz · Director
  • Vijay M. Lathi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ronald Krasnow, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Aug 8, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Relypsa Inc chose not to state its revenue in its newest notice of a funding round (Dec 2012).

    SEC Form D · Dec 2012

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2012

That is all the official record says: Relypsa Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

11 named in official filings. Open an investor to see everything it has backed.

Investors in Relypsa Inc
InvestorKindAmountRoundRoleSource
5AM Co-Investors III, L.P.Fund or asset managernot statednot statedHeld Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
5am Co-Investors II LPFund or asset managernot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
5AM Partners III, LLCFund or asset managernot statednot statedHeld Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
5AM Partners II, LLCFund or asset managernot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
5am Ventures III, L.P.Venture capitalnot statednot statedHeld Series C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
5AM Ventures II LPVenture capitalnot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
New Leaf Venture Management I, L.L.C.Venture capitalnot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013)SEC Form 3
New Leaf Venture Management I, L.P.Venture capitalnot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013)SEC Form 3
New Leaf Ventures I, L.P.Venture capitalnot statednot statedHeld Series A-1, B-1, B-2, C-1 and C-2 preferred (Form 3, 2013)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3
OrbiMed Capital GP IV LLCFund or asset managernot statednot statedHeld Series B-1, B-2, C-1 and C-2 preferred stock, 10% owner (Form 3, 2013)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Relypsa Inc
NameRoleNamed in
Claire M. LockeyExecutive officerDec 2012
Gerrit KlaernerExecutive officerDec 2012
Jerry M. BuysseExecutive officerDec 2012
Lance M. BermanExecutive officerDec 2012
Ronald KrasnowExecutive officerDec 2012
Wilhelm M. StahlExecutive officerDec 2012
Jim M. JohnsonExecutive officerAug 2012
Gerrit KlaernerDirectorDec 2012
Jonathan M. SilversteinDirectorDec 2012
Klaus M. VeitingerDirectorDec 2012
Paul M. HastingsDirectorDec 2012
Ron M. HuntDirectorDec 2012
Scott M. RocklageDirectorDec 2012
Thomas M. SchuetzDirectorDec 2012
Deepa M. PakianathanDirectorOct 2012
Vijay M. LathiDirectorAug 2011
Janis M. NaeveDirectorSep 2010